V6 Anti-Human ActRII (Bimagrumab)
Product Specifications
Expression System
CHO
Reactivity
Human
Target
ActRII
Purification
Protein A
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Buffer
ABDB-1002 or PBS, pH 7.4, Contains no stabilizers or preservatives.
Storage Conditions
The product need to be stored at the original stock concentration at 4°C.Avoid freeze / thaw cycle.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives
Sterility
0.2 μM filtered
Isotype
Human IgG1 (K214R/L234A/L235A) -kappa
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6193719-01 0.1 mL
CD45 (B220, CD45R, GP180, Leukocyte common antigen (LCA), Loc, Ly-5, Lyt-4, Protein tyrosine phosphatase receptor type C (PTPRC), Receptor-type tyrosine-protein phosphatase C, T200 glycoprotein) (BSA & Azide Free) (MaxLight 405)
Sign In for Pricing
View Details MBS6193719-02 5x 0.1 mL
CD45 (B220, CD45R, GP180, Leukocyte common antigen (LCA), Loc, Ly-5, Lyt-4, Protein tyrosine phosphatase receptor type C (PTPRC), Receptor-type tyrosine-protein phosphatase C, T200 glycoprotein) (BSA & Azide Free) (MaxLight 405)
Sign In for Pricing
View Details 
MBS6430702-01 0.1 mL
PCDHA2 (Protocadherin alpha-2, PCDH-alpha2) (HRP)
Sign In for Pricing
View Details 
MBS6430702-02 5x 0.1 mL
PCDHA2 (Protocadherin alpha-2, PCDH-alpha2) (HRP)
Sign In for Pricing
View Details 